Association of microglia loss with hippocampal network impairments as a turning point in the amyloid pathology progression.
Giusy PizzirussoiD, Efthalia Preka, Julen GoikoleaiD, Celia Aguilar-Ruiz, Patricia Rodriguez‐RodrigueziD, Guillermo Vazquez Cabrera, Simona Laterza, María Latorre‐LealiD, Francesca Eroli, Klas BlomgreniD, Silvia MaioliiD, Per NilssoniD, Adamantia F. FragopoulouiD, André FisahniD, Luis Enrique Arroyo‐GarcíaiD
Abstract
Alzheimers disease is a progressive neurological disorder causing memory loss and cognitive decline. The underlying causes of cognitive deterioration and neurodegeneration remain unclear, leading to a lack of effective strategies to prevent dementia. Recent evidence highlights the role of neuroinflammation, particularly involving microglia, in Alzheimers disease onset and progression. Characterizing the initial phase of Alzheimers disease can lead to the discovery of new biomarkers and therapeutic targets, facilitating timely interventions for effective treatments. We used the AppNL-G-F knock-in mouse model, which resembles the amyloid pathology and neuroinflammatory characteristics of Alzheimers disease, to investigate the transition from a pre-plaque to an early plaque stage with a combined functional and molecular approach. Our experiments show a progressive decrease in the power of cognition-relevant hippocampal gamma oscillations during the early stage of amyloid pathology, together with a modification of fast-spiking interneuron intrinsic properties and postsynaptic input. Consistently, transcriptomic analyses revealed that these effects are accompanied by changes in synaptic function-associated pathways. Concurrently, homeostasis-and inflammatory-related microglia signature genes were downregulated. Moreover, we found a decrease in Iba1-positive microglia in the hippocampus that correlates with plaque aggregation and neuronal dysfunction. Collectively, these findings support the hypothesis that microglia play a protective role during the early stages of amyloid pathology by preventing plaque aggregation, supporting neuronal homeostasis, and overall preserving the oscillatory networks functionality. These results suggest that the early loss of microglia could be a pivotal event in the progression of Alzheimers disease, potentially triggering plaque deposition, impairment of fast-spiking interneurons, and the breakdown of the oscillatory circuitry in the hippocampus.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease
Aurélien M. Badina, Kelly Ceyzériat, … Benjamin B. Tournier·Neurobiology of DiseasePeer-reviewed·May 8, 2025
- Microglia initially seed and later reshape amyloid plaques in Alzheimer's disease
Nóra Baligács, Giulia Albertini, … Bart De Strooper·Nature CommunicationsPeer-reviewed·Dec 5, 2024
- Cytokine expression patterns predict suppression of vulnerable neural circuits in a mouse model of Alzheimer's disease
Dennis Chun Yin Chan, ChaeMin Kim, … Elizabeth A. Proctor·bioRxiv·Mar 17, 2024
- Myelin maturation failure and oligodendrocyte precursor loss underlie default mode network disruption in a humanized APP knock-in model of Alzheimers disease
Esmin Unaran, Olamide Elizabeth Adebiyi, … Ravi S. Menon·bioRxiv·Aug 22, 2026
- APPNL-F knock-in Alzheimer's Disease model mice reveal etiological convergence of aging and amyloidosis
Matthieu Prieur, Anne-Laure Hemonnot-Girard, … Hélène Hirbec·bioRxiv·Jan 31, 2026
- Ageing-associated myelin dysfunction drives amyloid deposition in mouse models of Alzheimer's disease
Constanze Depp, Ting Sun, … Klaus‐Armin Nave·NaturePeer-reviewed·May 31, 2023